$heff's $tation of $tocks & $olid DD

[Bio_pete]

ONCE - Pick your reason for the selloff, reimbursement questions, market size, how long the visual improvement will last, failed one of the secondary endpoints (visual acuity - ability to read letters).

The company mentions one boy in an earlier study who could play baseball after his treatments & read. Investors believed the treatments were a cure for blindness but its not quite that dramatic. If you've watched the earlier videos then being able to navigate the maze is a huge improvement but it may take time for investors to appreciate the significance.

I think its a buy at these levels but it wouldn't surprise me to see it trade another $5 lower.